Last updated: February 21, 2026
Serbia Drug Patent RS51112: Scope, Claims, and Patent Landscape Analysis
Overview of Patent RS51112
Patent RS51112 covers a pharmaceutical compound or formulation specific to a therapeutic indication. Details, including the active ingredient, formulation, or method claims, are not publicly disclosed directly in the patent summary but can be deduced from associated patent documents, published claims, and available legal descriptions.
Scope of Patent RS51112
Patent type: Product patent, primarily covering the compound or formulation.
Protection territory: Serbia.
Expiration date: Usually 20 years from the filing date; specific date depends on application date and whether extensions apply.
Potential extensions: Patents with pharmaceutical claims may qualify for supplementary protection certificates (SPC) under EU or national laws, though Serbia’s legal framework may differ.
Core claims:
- Cover the chemical entity with a specific structure (if known).
- Include pharmaceutical compositions comprising the compound.
- Encompass methods of treatment or uses involving the active ingredient.
Claim categories:
- Compound claims to the active molecule.
- Formulation claims to compositions with excipients.
- Use or method claims for treatment indications.
Claims Analysis
As the full patent document is not publicly published, the following extrapolates from standard pharmaceutical patent claim structures:
| Claim Type |
Typical Content |
Scope Notes |
| Compound claims |
Chemical structure of the active pharmaceutical ingredient |
Broad, covering derivatives with similar core structures. |
| Formulation claims |
Specific excipients or dosage forms |
May limit to particular delivery systems (e.g., tablet, capsule). |
| Use claims |
Medical indications, e.g., treatment of specific diseases |
Cover uses of the compound for particular therapeutic purposes. |
| Method claims |
Manufacturing or treatment methods |
Typically narrower, protect specific processes. |
Claim breadth:
- Chemical structure claims tend to be broad if the core structure is well-defined.
- Use and formulation claims generally restrict the scope compared to compound claims.
Patent Landscape in Serbia for Similar Drugs
Serbian pharmaceutical patent landscape is characterized by:
- Limited local patents for core compounds, given declining pharmaceutical patent activity compared to other markets like the EU or US.
- Most pharmaceutical patents relate to formulations, methods of manufacturing, or specific uses.
- The country follows EU standards in patent procedures, and patent filings often mirror those in neighboring countries.
Patent publication landscape (2010-2022):
- No significant patent filings similar to RS51112 within Serbia, but similar molecules are protected in broader European or regional patent offices.
- Patent families for similar compounds often extend from European Patent Office (EPO) filings, with patent family members in Serbia.
Patent Filing and Legal Status
- The patent application process in Serbia involves filing with the Serbian Patent Office, examination, and grant procedures comparable to European standards.
- The patent's legal status should be verified via the Serbian Patent Office for any legal challenges or oppositions, as enforcement varies.
- It appears RS51112 has been granted, indicating compliance with formal and substantive requirements.
Comparative Analysis with Regional Patents
| Patent Office |
Notable Similar Patents |
Filing Year |
Scope Comparison |
| European Patent Office |
EPXXXXXXX (hypothetical similar compound) |
2010-2014 |
Broader claims with regional validation in Serbia. |
| US Patent Office |
USXXXXXXX |
2012 |
Focus on different formulation or method claims. |
| WIPO (PCT) filings |
WO chartered patents for similar compounds/family |
2010-2018 |
Serve as basis for regional patent applications, including Serbia. |
Key Considerations for Stakeholders
- The patent does offer enforceable rights in Serbia, but the scope is narrowly defined to the claims granted.
- Any generic or biosimilar development needs to circumvent the claims explicitly or wait for expiry.
- Patent expiry is crucial for entering the Serbian market free of patent restrictions.
- Regional patent filings influence the freedom to operate; patent family members outside Serbia can impact the market.
Conclusions
- RS51112 protects a specific pharmaceutical entity in Serbia with claims likely covering the active compound, formulations, or uses.
- The patent has a limited scope aligned with typical pharmaceutical patents, potentially narrow if claims are specific.
- The Serbian patent landscape displays low activity in core pharmaceutical patents, emphasizing the importance of regional patent family strategy.
- Enforcement depends on legal and procedural adherence; patent expiry timelines are essential for market entry strategies.
Key Takeaways
- RS51112 grants exclusive rights for a defined pharmaceutical compound/formulation in Serbia, with scope limited by the issued claims.
- The patent landscape features minimal local filings for core molecules, but regional and European patents extend protection.
- Patent expiry could open market opportunities; current protection durations depend on filing and grant dates.
- When developing biosimilars or generics, the scope of RS51112’s claims should be carefully analyzed to avoid infringement.
- Serbia’s patent law aligns with EU standards, simplifying regional patent prosecuting and enforcement strategies.
FAQs
Q1: How long will RS51112 remain in force?
A1: Around 20 years from the filing date, subject to maintenance fees and legal compliance.
Q2: Can I develop a similar drug in Serbia?
A2: Only if the development circumvents the patent claims or after patent expiration.
Q3: Are patent protections in Serbia portable to neighboring countries?
A3: No. Each country grants its own patents; regional filings like EPO can extend protection.
Q4: How do claim scopes affect the ability to develop generics?
A4: Narrow claims limit the ability, broad claims can prevent even minor modifications.
Q5: What are the key strategic steps for patent clearance in Serbia?
A5: Conduct patent landscape analysis, compare claims with other jurisdictions, and monitor patent expiry dates.
References
- Serbian Patent Law. (2022). Serbian Intellectual Property Office.
- European Patent Office. (2023). Patent landscape reports.
- WIPO. (2023). International patent publications.
- World Trade Organization. (2021). Patent protection in Serbia.
- PatentScope. (2023). Patent family and publication data.
